Screener
MoonLake Immunotherapeutics MLTX Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 8:55 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001821586-26-000007
| (in thousands, except share and per share data) | March 31, 2026 (Unaudited) | December 31, 2025 |
|---|---|---|
| Non-current assets | ||
| Operating lease right-of-use assets | 1,857 | 1,566 |
| Property and equipment, net | 532 | 577 |
| Other non-current assets | 1,344 | 596 |
| Total non-current assets | 3,733 | 2,739 |
| Total assets | $400,374 | $424,433 |
| Liabilities and Equity | ||
| Current liabilities |
Item 1. Financial Statements (Unaudited)
FAQ
- What is MoonLake Immunotherapeutics's deferred tax assets and other non-current assets?
- MoonLake Immunotherapeutics (MLTX) reported deferred tax assets and other non-current assets of $1.34M in Q1 2026.
- How has MoonLake Immunotherapeutics's deferred tax assets and other non-current assets changed year-over-year?
- MoonLake Immunotherapeutics's deferred tax assets and other non-current assets decreased by 20.8% year-over-year, from $1.7M to $1.34M.
Ask your AI about MoonLake Immunotherapeutics's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude